Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination | NEJM
posted 2 weeks
Mashup Score: 529
New England Journal of Medicine (NEJM) - Clinical Decisions from The New England Journal of Medicine — Delayed Second Dose versus Standard Regimen for Covid-19...
TCT Meetings - 2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - Graft versus host disease (GVHD) is the leading cause of non-relapse mortality...
#TCTM21 Post-transplant Cyclophosphamide reduces acute and chronic #GVHD without significant differences in infection, relapse, or overall survival after HLA matched allogeneic #HCT, a study from @ClevelandClinic @hamiltkyb @BldCancerDoc https://t.co/RRlbdjoeug
#TCTM21 – Transplant and Cellular Therapy Meetings of ASTCT and CIBMTR – Social Media Analytics and Transcripts
posted 3 weeks
Mashup Score: 7
Symplur - The TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT Meetings) are the combined annual meetings of the American Society...
Top Influencers of #TCTM21 👉 @ASTCT @DrMiguelPerales @BldCancerDoc @AkshaySharmaMD @CIBMTR @hmgcoa2 https://t.co/C9vOzeZpvw via @symplur
American Society of Hematology Publications - Key Points. With sufficient resources, HSCT can safely continue in the COVID-19 pandemic if primary responsibility for COVID-19 patients is not...
With sufficient resources, #HCT can safely continue in the #COVID19 pandemic: @DanaFarber cancer center experience @BloodAdvances #BMTsm https://t.co/yfmEmJrlzu
TCT Meetings - 2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - Introduction Monoclonal antibody (mAb)-targeting of CD117 (c-Kit) present on...
#TCTM21 Andriyana K. Bankova from @Stanford anti CD117 mAb + Azacytidine as an attractive novel conditioning agent for #HCT in #SickleCell disease (in mice) https://t.co/1HWqviIdf8 https://t.co/1HWqviIdf8
www.stjude.org - This virtual symposium will discuss hematopoietic stem cell transplantation (HSCT) and gene therapy (GT) for sickle cell disease, with a focus on topics such...
🚨Beginning shortly, #SickleCell Disease conference for patients, families, and providers. We will be discussing #BMT and #GeneTherapy for #SCD @StJudeResearch 👇 Here is the link https://t.co/gOAmfqbedl https://t.co/gOAmfqbedl
TCT Meetings - 2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - Introduction: The standard dose (50 mg/kg/day) and timing (days +3/+4) of PTCy...
#TCTM21 We know that PTCy is great, but wouldn't it be better if we could de-escalate the dose of PTCy 🧐 Data presented by Meredith Jo McAdams from @NIH suggests that PTCy 25mg/Kg on day +3/+4 might be just as effective. #BMTsm #GVHD https://t.co/ogRxOHFBTh https://t.co/ogRxOHFBTh
Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines | CDC
posted 3 weeks
Mashup Score: 2
Centers for Disease Control and Prevention - Find interim clinical considerations for the use of mRNA COVID-19...
🚨New guidance from @CDCgov for persons exposed to someone with #COVID19 🚨 Quarantine NOT required if: 1. Fully vaccinated ( ≥ 2 wks s/p 2nd dose of 2-dose vaccine or ≥ 2 wks s/p single dose vaccine) 2. Within 3 months of last dose 3. Asymptomatic https://t.co/076FDN7YMb
Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis
posted 2 weeks
Mashup Score: 2
OUP Academic - In this retrospective study of adult patients hospitalized with COVID-19, tocilizumab was associated with a 62% reduction in hazard of death. Tocilizumab may...
Tocilizumab may provide benefit in a subgroup of patients hospitalized with #COVID19 who have elevated biomarkers of hyperinflammation, without increasing the risk of secondary infection. https://t.co/kdj8qgl1RJ
TCT Meetings - 2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - Background. In vivo hematopoietic stem cell (HSC) gene therapy represents a...
#TCTM21 Impressive in-vivo gene therapy in a #thalassemia mouse model after mobilization with MGTA-145: Chang Li https://t.co/JRMvgCFIb6 https://t.co/JRMvgCFIb6
Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination | @NEJM https://t.co/VyRyuoBVRs